Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Occhipinti

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Cardiology|December 14, 2020
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systemsPiera Capranzano, Bruno Francaviglia, Andrea Sardone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 25, 2024
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysisMattia Galli, Claudio Laudani, Giovanni Occhipinti, et al.
JACC. Case Reports|March 21, 2025
The Novel A-Flux Coronary Sinus Reducer Normalizes Coronary Microvascular Function in a Persistently Symptomatic PatientGiovanni Occhipinti, Anthony Salazar-Rodriguez, Francesco Giannini, et al.
Clinical Pharmacology and Therapeutics|February 27, 2026
Safety and Efficacy of Colchicine across the Spectrum of Coronary Artery Disease: A Systematic Review and Meta-Analysis of 20 Randomized TrialsClaudio Laudani, Kamil Bujak, Giovanni Occhipinti, et al.
JACC. Cardiovascular Interventions|March 19, 2021
Determinants of Popularity and Natural History of Social Media Accounts in Interventional CardiologyPaolo D'Arrigo, Antonio Greco, Antonio Gabriele Franchina, et al.
Journal of Thrombosis and Thrombolysis|July 29, 2025
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibitionMassimiliano Camilli, Giovanni Occhipinti, Nicola Potere, et al.
Expert Review of Clinical Pharmacology|January 6, 2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapyClaudio Laudani, Luis Ortega-Paz, Francesco Franchi, et al.
Nature Communications|February 10, 2026
Evidence of megathrust earthquakes and seismic supercycles in subtropical Japan from millennia-old coral microatollsSophie Debaecker, Nathalie Feuillet, Kenji Satake, et al.
Circulation|March 13, 2023
Pharmacology and Clinical Development of Factor XI InhibitorsAntonio Greco, Claudio Laudani, Marco Spagnolo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysisMattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|December 14, 2020
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systemsPiera Capranzano, Bruno Francaviglia, Andrea Sardone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 25, 2024
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysisMattia Galli, Claudio Laudani, Giovanni Occhipinti, et al.
JACC. Case Reports|March 21, 2025
The Novel A-Flux Coronary Sinus Reducer Normalizes Coronary Microvascular Function in a Persistently Symptomatic PatientGiovanni Occhipinti, Anthony Salazar-Rodriguez, Francesco Giannini, et al.
Clinical Pharmacology and Therapeutics|February 27, 2026
Safety and Efficacy of Colchicine across the Spectrum of Coronary Artery Disease: A Systematic Review and Meta-Analysis of 20 Randomized TrialsClaudio Laudani, Kamil Bujak, Giovanni Occhipinti, et al.
JACC. Cardiovascular Interventions|March 19, 2021
Determinants of Popularity and Natural History of Social Media Accounts in Interventional CardiologyPaolo D'Arrigo, Antonio Greco, Antonio Gabriele Franchina, et al.
Journal of Thrombosis and Thrombolysis|July 29, 2025
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibitionMassimiliano Camilli, Giovanni Occhipinti, Nicola Potere, et al.
Expert Review of Clinical Pharmacology|January 6, 2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapyClaudio Laudani, Luis Ortega-Paz, Francesco Franchi, et al.
Nature Communications|February 10, 2026
Evidence of megathrust earthquakes and seismic supercycles in subtropical Japan from millennia-old coral microatollsSophie Debaecker, Nathalie Feuillet, Kenji Satake, et al.
Circulation|March 13, 2023
Pharmacology and Clinical Development of Factor XI InhibitorsAntonio Greco, Claudio Laudani, Marco Spagnolo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysisMattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
Pageof 10